Fortinet (NASDAQ: FTNT) - Do Nothing - Q3 FY12/26 Earnings Review
Fortinet’s revenue rose 20% to $2.08 billion, but its 15% Q4 growth guide drove a 25% post-earnings stock drop as product, billings and services growth decelerated.
Fortinet’s revenue rose 20% to $2.08 billion, but its 15% Q4 growth guide drove a 25% post-earnings stock drop as product, billings and services growth decelerated.
Voss Capital Issues Open Letter to the Board of Euronet Worldwide $EEFT https://t.co/ZpE7cH201Q
Insider buys usually feel like PR fluff. But $45M into $KKR at these levels is clearly an investment, not signaling. Especially meaningful coming from guys whose entire schtick is figuring out what things are worth... https://t.co/w5KSbF0VMj
Well, looks like $RKT vacuumed up the entire industry's refi volumes. Not only PennyMac. And 30 yr fixed just hit the lowest in 3.5 years this week. https://t.co/fqJ4bNkmiF
Been awhile since we found some Of the deep value we built ADW Capital around… should be interesting. https://t.co/E2eHeIKQDO $CODI
I sent out our Q4 investor letter last week. I wrote up my investment thesis on $TFSL. If you haven't seen it and are an accredited investor, DM me your email address, and I will send it over.
$FIX just a casual 24-bagger in the last five years
Oracle rose about 12% intraday on October 28, 2026 as AI infrastructure and cloud-demand sentiment improved and credit-spread concerns…
Group 1 Automotive trades at 5.5 times earnings as aging gasoline vehicles and EV repairs sustain service profits; insiders bought while…
Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…
Daktronics, the leader in U.S. sports video boards, targets 10-12% EBIT margins after shifting production to China and Mexico and exiting…
Danaher’s new CEO paired a Q3 beat and raised EPS outlook with a 2027 4%-5% organic-growth starting point, while pitching AI-enabled…
Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…
Enova’s Q3 2026 revenue exceeded $1 billion as originations rose 31%, while its failed Grasshopper Bank bid drove a 23% one-day stock…
Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…
Xenia Hotels & Resorts pairs luxury hotel assets, brand affiliations and planned renovations with investment-grade credit and covered…
Innodata shares fell 25% to $44.74 after India Today reported 550 job cuts in India.
EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt…
GFL’s take-private structure hinges on BC Partners rolling 60% of its stake to preserve debt portability under the 40% permitted-holder…
Lumentum’s 2027 optical-chip expansion, 200G EML and CW capacity, silicon-photonics roadmap, pricing and 3.2T module prospects face…
Novartis grew Q3 sales 4% to $14.5bn and raised profit guidance, but pipeline failures triggered a $1.9bn impairment as net debt reached…
AppFolio grew third-quarter revenue 19% as Realm-X AI agents gained adoption, lifting guidance to $1.122 billion to $1.127 billion.
Boeing posted $24.2 billion in Q3 revenue and $1.5 billion in operating cash flow, but commercial aircraft lost $697 million as production…
TTM Technologies’ record Q3 and data-center exposure drove a 27.7% stock drop as investors questioned debt-funded growth, leverage and the…
Neoclouds face tighter debt financing as AI infrastructure capex outruns cash flow, leaving cash-burning GPU providers more exposed than…
Quantinuum’s trapped-ion quantum platform supports a $2 billion 2030 revenue estimate and $135 fair value, backed by $2.1 billion cash and…
Reddit generated $805 million in Q2 2026 revenue, 95% from ads, but slowing Google search referrals expose AI-driven traffic and…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.